Pharmaceutical company Novartis has acquired a 15% stake in Gamida Cell, which develops stem cell population expansion technologies, for $35m, with an option to buy it for up to $600m.

Recently floated spin-out Pixium Vision is also involved in the project.

$10,000 is needed to fund the research through Science Exchange.

Senior care technology company Healthsense has received $10m in a round featuring Merck's corporate venturing unit.

Healthcare app Chunyu, already backed by Bertelsmann, raised $50m in a series C round featuring CICC and Dunan Holding.

KoolSpan and BrainScope both attract funding totaling $700,000.

Virginia University spin-out PhosImmune has raised investment from the Centre for Innovative Technology.